Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 21, 2019 Filed Jun 21, 2019 20:29 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 6,290 | $144.07 | $906,200.30 |
DisclosureSEC source: 0001209191-19-038469 · doc4.xml · nonDerivative · entry 5 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,565 F4 · shares: This Exercise and sale of a total of 19,986 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. F6 · price: Price reflects a weighted average sale price for multiple transactions ranging from $143.77 to $144.52 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F7 · balance_after: 21,720 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; 4,240 on May 31, 2022 and 2,780 on May 31, 2023. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 20:29 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 13,696 | $143.17 | $1,960,856.32 |
DisclosureSEC source: 0001209191-19-038469 · doc4.xml · nonDerivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,855 F4 · shares: This Exercise and sale of a total of 19,986 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $142.75 to $143.74 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 21, 2019 Filed Jun 21, 2019 20:29 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Exercise / conversionOrdinary Shares | 19,986 | $45.34 | $906,165.24 |
DisclosureSEC source: 0001209191-19-038469 · doc4.xml · nonDerivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This option to purchase 22,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 22,000 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. F4 · shares: This Exercise and sale of a total of 19,986 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 20:29 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,014 | $0.00 Strike: $45.34 | $0.00 |
DisclosureSEC source: 0001209191-19-038469 · doc4.xml · derivative · entry 7 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,986 Underlying: Ordinary Shares · 22,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 22,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 22,000 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 20:29 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Sahres | 2,014 | $146.12 | $294,285.68 |
DisclosureSEC source: 0001209191-19-038469 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,565 F1 · shares: This Exercise and sale of a total of 2,014 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $146.00 to $146.62 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 20:29 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Exercise / conversionOrdinary Shares | 2,014 | $45.34 | $91,314.76 |
DisclosureSEC source: 0001209191-19-038469 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Exercise and sale of a total of 2,014 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. F2 · shares: This option to purchase 22,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 22,000 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 20:27 UTC |
Bardwell KathleenSr.V. P. & C.C.O.
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,360 | $0.00 Strike: $45.34 | $0.00 |
DisclosureSEC source: 0001209191-19-038467 · doc4.xml · derivative · entry 3 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,360 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 5,360 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 5,360 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 20:27 UTC |
Bardwell KathleenSr.V. P. & C.C.O.
|
SaleOrdinary Shares | 5,360 | $145.05 | $777,468.00 |
DisclosureSEC source: 0001209191-19-038467 · doc4.xml · nonDerivative · entry 2 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,428 F1 · shares: This Exercise and sale of a total of 5,360 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $145.00 to $145.12 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: 3,646 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 148 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021; 148 on June 1, 2021; 393 on May 31, 2022; 148 on May 31, 2022 and 148 on May 31, 2023. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 20:27 UTC |
Bardwell KathleenSr.V. P. & C.C.O.
|
Exercise / conversionOrdinary Shares | 5,360 | $45.34 | $243,022.40 |
DisclosureSEC source: 0001209191-19-038467 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Exercise and sale of a total of 5,360 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 22, 2019. F2 · shares: This option to purchase 5,360 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 5,360 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. F3 · balance_after: 3,646 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 148 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021; 148 on June 1, 2021; 393 on May 31, 2022; 148 on May 31, 2022 and 148 on May 31, 2023. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 20:47 UTC |
Steeves Richard MartinDirector
|
SaleOrdinary Shares | 10,849 | $138.02 | $1,497,378.98 |
DisclosureSEC source: 0001209191-19-036108 · doc4.xml · nonDerivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 0 F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $137.76 to $138.25 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 20:47 UTC |
Steeves Richard MartinDirector
|
SaleOrdinary Shares | 22,644 | $137.36 | $3,110,379.84 |
DisclosureSEC source: 0001209191-19-036108 · doc4.xml · nonDerivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 10,849 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $136.73 to $137.68 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 20:47 UTC |
Steeves Richard MartinDirector
|
SaleOrdinary Shares | 188,000 | $137.91 | $25,927,080.00 |
DisclosureSEC source: 0001209191-19-036108 · doc4.xml · nonDerivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $137.56 to $138.35 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 21:02 UTC |
Steeves Richard MartinDirector
|
SaleOrdinary Shares | 2,302 | $137.60 | $316,755.20 |
DisclosureSEC source: 0001209191-19-035849 · doc4.xml · nonDerivative · entry 4 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 33,493 F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $137.56 to $137.67 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 21:02 UTC |
Steeves Richard MartinDirector
|
SaleOrdinary Shares | 53,000 | $136.93 | $7,257,290.00 |
DisclosureSEC source: 0001209191-19-035849 · doc4.xml · nonDerivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 35,795 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $136.56 to $137.55 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 21:02 UTC |
Steeves Richard MartinDirector
|
SaleOrdinary Shares | 17,565 | $136.24 | $2,393,055.60 |
DisclosureSEC source: 0001209191-19-035849 · doc4.xml · nonDerivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 88,795 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $135.56 to $136.55 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| June 05, 2019 Filed Jun 6, 2019 20:50 UTC |
Steeves Richard MartinDirector
|
SaleOrdinary Shares | 19,838 | $136.60 | $2,709,870.80 |
DisclosureSEC source: 0001209191-19-035114 · doc4.xml · nonDerivative · entry 5 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 106,360 F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $136.34 to $136.98 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| June 05, 2019 Filed Jun 6, 2019 20:50 UTC |
Steeves Richard MartinDirector
|
SaleOrdinary Shares | 82,700 | $135.91 | $11,239,757.00 |
DisclosureSEC source: 0001209191-19-035114 · doc4.xml · nonDerivative · entry 4 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 126,198 F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $135.34 to $136.33 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:36 UTC |
WILSON LOYAL WDirector
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 3,133 | $0.00 Strike: $32.34 | $0.00 |
DisclosureSEC source: 0001209191-19-034756 · doc4.xml · derivative · entry 4 WILSON LOYAL W · CIK 0001237389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,133 shares Expires 2020-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:36 UTC |
WILSON LOYAL WDirector
|
SaleOrdinary Shares | 5,156 | $135.64 | $699,359.84 |
DisclosureSEC source: 0001209191-19-034756 · doc4.xml · nonDerivative · entry 3 WILSON LOYAL W · CIK 0001237389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $135.62 to $135.71 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:36 UTC |
WILSON LOYAL WDirector
|
SaleOrdinary Shares | 3,133 | $135.91 | $425,806.03 |
DisclosureSEC source: 0001209191-19-034756 · doc4.xml · nonDerivative · entry 2 WILSON LOYAL W · CIK 0001237389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,156 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $135.83 to $135.93 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:36 UTC |
WILSON LOYAL WDirector
|
Exercise / conversionOrdinary Shares | 3,133 | $32.34 | $101,321.22 |
DisclosureSEC source: 0001209191-19-034756 · doc4.xml · nonDerivative · entry 1 WILSON LOYAL W · CIK 0001237389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,289 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:29 UTC |
Burton Karen LVP, Controller & CAO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,700 | $0.00 Strike: $29.94 | $0.00 |
DisclosureSEC source: 0001209191-19-034744 · doc4.xml · derivative · entry 6 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,700 shares Expires 2022-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 3,700 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,700 Old STERIS ordinary shares for $29.94 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:29 UTC |
Burton Karen LVP, Controller & CAO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,800 | $0.00 Strike: $36.09 | $0.00 |
DisclosureSEC source: 0001209191-19-034744 · doc4.xml · derivative · entry 5 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,800 shares Expires 2021-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 3,800 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,800 Old STERIS ordinary shares for $36.09 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:29 UTC |
Burton Karen LVP, Controller & CAO
|
SaleOrdinary Shares | 3,700 | $135.00 | $499,500.00 |
DisclosureSEC source: 0001209191-19-034744 · doc4.xml · nonDerivative · entry 4 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,808 F3 · shares: This Exercise and sale of a total of 3,700 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 16, 2019. F5 · balance_after: 7,272 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 700 on October 1, 2019; 1,220 on June 1, 2020; 3,000 on June 1, 2021; 1,332 on May 31, 2022; 765 on May 31, 2022 and 255 on May 31, 2023. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:29 UTC |
Burton Karen LVP, Controller & CAO
|
Exercise / conversionOrdinary Shares | 3,700 | $29.94 | $110,778.00 |
DisclosureSEC source: 0001209191-19-034744 · doc4.xml · nonDerivative · entry 3 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,508 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: This Exercise and sale of a total of 3,700 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 16, 2019. F4 · shares: This option to purchase 3,700 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,700 Old STERIS ordinary shares for $29.94 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:29 UTC |
Burton Karen LVP, Controller & CAO
|
SaleOrdinary Shares | 3,800 | $135.00 | $513,000.00 |
DisclosureSEC source: 0001209191-19-034744 · doc4.xml · nonDerivative · entry 2 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,808 F1 · shares: This Exercise and sale of a total of 3,800 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 16, 2019. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:29 UTC |
Burton Karen LVP, Controller & CAO
|
Exercise / conversionOrdinary Shares | 3,800 | $36.09 | $137,142.00 |
DisclosureSEC source: 0001209191-19-034744 · doc4.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Exercise and sale of a total of 3,800 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 16, 2019. F2 · shares: This option to purchase 3,800 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,800 Old STERIS ordinary shares for $36.09 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 20:50 UTC |
Steeves Richard MartinDirector
|
SaleOrdinary Shares | 3,659 | $136.07 | $497,880.13 |
DisclosureSEC source: 0001209191-19-035114 · doc4.xml · nonDerivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 208,898 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $136.01 to $136.17 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 20:50 UTC |
Steeves Richard MartinDirector
|
SaleOrdinary Shares | 107,000 | $135.36 | $14,483,520.00 |
DisclosureSEC source: 0001209191-19-035114 · doc4.xml · nonDerivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 212,557 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $135.00 to $135.99 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| June 03, 2019 Filed Jun 3, 2019 20:34 UTC |
Burton Karen LVP, Controller & CAO
|
SaleOrdinary Shares | 1,387 | $133.89 | $185,705.43 |
DisclosureSEC source: 0001209191-19-033932 · doc4.xml · nonDerivative · entry 2 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,808 F2 · shares: This sale of a total of 1,387 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 16, 2019. F3 · balance_after: 7,272 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 700 on October 1, 2019; 1,220 on June 1, 2020; 3,000 on June 1, 2021; 1,332 on May 31, 2022; 765 on May 31, 2022 and 255 on May 31, 2023. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:34 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
Tax withholdingOrdinary Shares | 2,179 | $134.07 | $292,138.53 |
DisclosureSEC source: 0001209191-19-034752 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,123 F1 · shares: 2,179 shares were withheld from the 4,681 restricted shares that vested on May 28, 2019. These 2,179 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,681 ordinary shares were awarded to Mr. Rosebrough on June 1, 2016 as part of an award of 18,724 restricted shares. These vested shares were valued at the NYSE closing market price on June 3, 2019. The remaining restrictions on these ordinary shares lapse as follows: 4,681 on June 1, 2020. F2 · balance_after: These 52,123 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 32,360 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 2,597 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; and 2,597 on May 31, 2023. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:30 UTC |
Bardwell KathleenSr.V. P. & C.C.O.
|
Tax withholdingOrdinary Shares | 150 | $134.07 | $20,110.50 |
DisclosureSEC source: 0001209191-19-034745 · doc4.xml · nonDerivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,428 F1 · shares: 150 shares were withheld from the 500 restricted shares that vested on June 3, 2019. These 150 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 500 ordinary shares were awarded to Ms. Bardwell on June 1, 2016 as part of an award of 2,000 restricted shares. These vested shares were valued at the NYSE closing market price on June 3, 2019. The remaining restrictions on these ordinary shares lapse as follows: 500 on June 1, 2020. F2 · balance_after: 3,646 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 148 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021; 148 on June 1, 2021; 393 on May 31, 2022; 148 on May 31, 2022 and 148 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:42 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,204 | $0.00 Strike: $147.05 | $0.00 |
DisclosureSEC source: 0001209191-19-033949 · doc4.xml · derivative · entry 2 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,204 Underlying: Ordinary Shares · 3,204 shares Expires 2029-05-31 F3 · derivative.exercise_date: This option becomes exercisable as follows: 801 on June 1, 2020; 801 on June 1, 2021; 801 on May 31, 2022 and 801 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:42 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
GrantOrdinary Shares | 556 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-033949 · doc4.xml · nonDerivative · entry 1 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,657 F1 · shares: All 556 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 556 on May 31, 2023. F2 · balance_after: 2,452 of these ordinary shares are restricted. The restrictions on the ordinary shares lapse as follows: 600 on October 1, 2019; 400 on June 1, 2020; 412 on June 1, 2021; 484 on May 31, 2022 and 556 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:44 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
GrantEmployee Stock Option (right to buy) · Derivative | 19,244 | Not disclosed Strike: $147.05 | Not disclosed |
DisclosureSEC source: 0001209191-19-033953 · doc4.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,244 Underlying: Ordinary Shares · 19,244 shares Expires 2029-05-31 F4 · price: This option becomes exercisable as follows: 4,811 on June 1, 2020; 4,811 on June 1, 2021; 4,811 on May 31, 2022 and 4,811 on May 31, 2023. F4 · derivative.exercise_date: This option becomes exercisable as follows: 4,811 on June 1, 2020; 4,811 on June 1, 2021; 4,811 on May 31, 2022 and 4,811 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:44 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
SaleOrdinary Shares | 1,500 | $131.77 | $197,655.00 |
DisclosureSEC source: 0001209191-19-033953 · doc4.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,688 F3 · shares: This sale of a total of 1,500 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 16, 2019. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:44 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
GrantOrdinary Shares | 3,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-033953 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,188 F1 · shares: All 3,336 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,502 on May 31, 2022 and 834 on May 31, 2023. F2 · balance_after: 19,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on October 1, 2019; 2,500 on June 1, 2020; 6,000 on June 1, 2021; 3,636 on May 31, 2022; 2,502 on May 31, 2022 and 834 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:43 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 48,116 | $0.00 Strike: $147.05 | $0.00 |
DisclosureSEC source: 0001209191-19-033952 · doc4.xml · derivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,116 Underlying: Ordinary Shares · 48,116 shares Expires 2029-05-31 F4 · derivative.exercise_date: This option becomes exercisable as follows: 12,029 on June 1, 2020; 12,029 on June 1, 2021; 12,029 on May 31, 2022 and 12,029 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:43 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantOrdinary Shares | 2,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-033952 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,565 F1 · shares: All 2,780 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,780 on May 31, 2023. F2 · balance_after: 21,720 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; 4,240 on May 31, 2022 and 2,780 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:41 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 111,204 | $0.00 Strike: $147.05 | $0.00 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · derivative · entry 15 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,204 Underlying: Ordinary Shares · 111,204 shares Expires 2029-05-31 F15 · derivative.exercise_date: This option becomes exercisable as follows: 27,801 on June 1, 2020; 27,801 on June 1, 2021; 27,801 on May 31, 2022 and 27,801 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:41 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 59,000 | $0.00 Strike: $53.52 | $0.00 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · derivative · entry 14 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 59,000 shares Expires 2024-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 119,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 119,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:41 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
GrantOrdinary Shares | 10,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 11 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,302 F12 · shares: All 10,388 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,597 on June 1, 2020; 2,597 on June 1, 2021; 2,597 on May 31, 2022 and 2,597 on May 31, 2023. F13 · balance_after: These 54,302 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 37,041 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 2,597 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; and 2,597 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:41 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 1,875 | $132.55 | $248,531.25 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 10 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,914 F8 · shares: This exercise and sale of a total of 59,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 15, 2019. F11 · price: Price reflects a weighted average sale price for multiple transactions ranging from $132.44 to $132.68 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:41 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 29,083 | $132.06 | $3,840,700.98 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 9 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,789 F8 · shares: This exercise and sale of a total of 59,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 15, 2019. F10 · price: Price reflects a weighted average sale price for multiple transactions ranging from $131.41 to $132.40 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:41 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 28,042 | $130.84 | $3,669,015.28 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 8 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,872 F8 · shares: This exercise and sale of a total of 59,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 15, 2019. F9 · price: Price reflects a weighted average sale price for multiple transactions ranging from $130.39 to $131.38 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:41 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
Exercise / conversionOrdinary Shares | 59,000 | $53.52 | $3,157,680.00 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 7 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: This option to purchase 119,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 119,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. F8 · shares: This exercise and sale of a total of 59,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 15, 2019. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:41 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
Tax withholdingOrdinary Shares | 1,436 | $133.68 | $191,964.48 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 6 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,914 F7 · shares: 1,436 shares were withheld from the 3,097 restricted shares that vested on May 31, 2019. These 1,436 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 3,097 ordinary shares were awarded to Mr. Rosebrough on May 31, 2018 as part of an award of 12,388 restricted shares. These vested shares were valued at the NYSE closing market price on May 31, 2019. The remaining restrictions on these ordinary shares lapse as follows: 3,097 on June 1, 2020; 3,097 on June 1, 2021 and 3,097 on May 31, 2022. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:40 UTC |
Majors Cary LVP, N America Com Operations
|
GrantEmployee Stock Option (right to buy) · Derivative | 12,828 | $0.00 Strike: $147.05 | $0.00 |
DisclosureSEC source: 0001209191-19-033946 · doc4.xml · derivative · entry 2 Majors Cary L · CIK 0001776271 · VP, N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,828 Underlying: Ordinary Shares · 12,828 shares Expires 2029-05-31 F3 · derivative.exercise_date: This option becomes exercisable as follows: 3,207 on June 1, 2020; 3,207 on June 1, 2021; 3,207 on May 31, 2022 and 3,207 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:40 UTC |
Majors Cary LVP, N America Com Operations
|
GrantOrdinary Shares | 2,224 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-033946 · doc4.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · VP, N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,195 F1 · shares: All 2,224 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,224 on May 31, 2023. F2 · balance_after: 16,744 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,000 on October 1, 2019; 2,500 on June 1, 2020; 6,500 on May 31, 2021; 2,520 on May 31, 2022; and 2,224 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:39 UTC |
deZwaan MichielV.P., Human Resources & CHRO
|
GrantEmployee Stock Option (right to buy) · Derivative | 12,828 | $0.00 Strike: $147.05 | $0.00 |
DisclosureSEC source: 0001209191-19-033943 · doc4.xml · derivative · entry 2 deZwaan Michiel · CIK 0001616395 · V.P., Human Resources & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,828 Underlying: Ordinary Shares · 12,828 shares Expires 2029-05-31 F3 · derivative.exercise_date: This option becomes exercisable as follows: 3,207 on June 1, 2020; 3,207 on June 1, 2021; 3,207 on May 31, 2022 and 3,207 on May 31, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.